Re: Iron Chelator For Bone RegrowthOn Jan 11, 9:34 pm, ironjustice <teamtan...@hotmail . com > wrote:
* litiasisrenal.uib . es /3inform/fitato/2Ang/fitatTa.html
"A rise of plasma phytate was produced at 15 days" <<
Hmmm .. about two weeks .. ? Jeez .. I've heard that before ..
* tinyurl . com /2rup87
This article shows .. clearly .. the TARGETING of the .. iron .. IN
those with arthritis leads to improved .. i-m-p-r-o-v-e-d ..
anemia .. in two weeks.
Clin Exp Rheumatol. 1986
Jan-Mar;4(1):25-9. Related Articles, Links
Antianemic and potential anti-inflammatory activity of
desferrioxamine: possible usefulness in rheumatoid arthritis.
Giordano N, Sancasciani S, Borghi C, Fioravanti A, Marcolongo R.
In order to study the role of excessive synovial iron sequestration
in
the production of anemia in rheumatoid arthritis (RA), the antianemic
efficacy and anti-inflammatory effect of desferrioxamine administered
in a
short-term
treatment (14 days), were evaluated in 10 patients suffering from
classic or definite RA and hyposideremic anemia.
Treatment with desferrioxamine showed an
elevated urinary iron excretion, a significant increase of serum
iron, UIBC and hemoglobin, and a marked progressive decrease
of serum ferritin. A moderate improvement of the pain intensity,
morning
stiffness and Ritchie's index was also observed.
The results obtained suggest that excessive reticuloendothelial
iron deposits occur in RA and that the iron uptake can be an
important factor in the production of anemia.
Desferrioxamine seems to be useful in
the treatment of patients suffering from RA and anemia, in order to
release iron from synovial tissue, reduce the inflammatory process
and improve anemia, changing an anemia which is typically resistant
to the martial therapy into an iron-sensitive anemia.
Publication Types:
Clinical Trial
PMID: 3516495 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------------------
Desferrioxamine maleateDesferrioxamine is a medicine that binds to
excess iron in the body. ... In these cases, desferrioxamine may be
given at the time of the blood transfusion, ...
w w w .tiscali.co.uk/lifestyle/healthfitness/health advice/netdoctor/arc...
- 42k - Cached - Similar pages
Deferoxamine - Wikipedia, the free encyclopediaDeferoxamine,
otherwise
known as desferrioxamine or desferal, is a chelating agent used to
remove excess iron from the body. It acts by binding free iron in ...
en.wikipedia.org/wiki/Desferrioxamine - 20k - Cached - Similar pages
Who loves ya.
Tom
Jesus Was A Vegetarian!
* jesuswasavegetarian.7h . com
Man Is A Herbivore!
* tinyurl . com /a3cc3
DEAD PEOPLE WALKING
* tinyurl . com /zk9fk
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian! * jesuswasavegetarian.7h . com
>
> Man Is A Herbivore! * tinyurl . com /a3cc3
>
> DEAD PEOPLE WALKING * tinyurl . com /zk9fk
>
>
>
> > On Jan 10, 8:34 am, ironjustice <ironjust...@cashette . com > wrote: A
> > drug originally used to treat iron poisoning <<
>
> > Bisphosphonate grows bone and it is an iron binder .. deferoxamine
> > binds irion and it grows bone .. CLA grows bone and is an iron
> > binder .. bringing us again to .. plain old iron binding
> > bisphosphonate .. **phytate** .
> > --------------------- * w w w .jacn.org/cgi/content/full/19/4/478S
>
> > Journal of the American College of Nutrition, Vol. 19, No. 4,
> > 478S-486S (2000)
> > Published by the American College of Nutrition
>
> > Conjugated Linoleic Acid and Bone Biology
> > Bruce A. Watkins, PhD, FACN and Mark F. Seifert, PhD
> > Purdue University, Department of Food Science, Lipid Chemistry and
> > Molecular Biology Laboratory, West Lafayette, Indiana, and Department
> > of Anatomy, Indiana University School of Medicine, Indianapolis,
> > Indiana
>
> > Address reprint requests to: Dr. B.A. Watkins, Department of Food
> > Science, Lipid Chemistry and Molecular Biology Laboratory, Purdue
> > University, W. Lafayette, IN, 47907. E-mail:
> > watk...@foodsci.purdue.edu.
>
> > ABSTRACT
> > Osteoporosis, osteoarthritis and inflammatory joint disease afflict
> > millions of people worldwide. Inflammatory cytokines inhibit
> > chondrocyte proliferation and induce cartilage degradation for which
> > part of the response is mediated by PGE2. Excess production of PGE2 is
> > linked to osteoporosis and arthritis and is associated with bone and
> > proteoglycan loss. PGE2 also influences the IGF-I/IGFBP axis to
> > facilitate bone and cartilage formation. Recent investigations with
> > growing rats given butter fat and supplements of CLA demonstrated an
> > increased rate of bone formation and reduced ex vivo bone PGE2
> > production, respectively. Furthermore, the supplements of CLA isomers
> > resulted in their enrichment in lipids of various bone compartments of
> > animals. The effects of CLA on bone biology in rats (IGF action and
> > cytokines) appear to be dependent on the level of n-6 and n-3 fatty
> > acids in the diet; however, these studies generally showed that CLA
> > decreased ex vivo bone PGE2 production and in osteoblast-like
> > cultures. Anti-inflammatory diets, including nutraceutical
> > applications of CLA, may be beneficial in moderating cyclooygenase 2
> > (COX-2) activity or expression (influencing PGE2 biosynthesis) and
> > might help to reduce rheumatoid arthritis (secondary osteoporosis).
> > This review summarizes findings of CLA on bone modeling in rats and
> > effects on cellular functions of osteoblasts and chondrocytes. These
> > experiments indicate that CLA isomers possess anti-inflammatory
> > activity in bone by moderating prostanoid formation.
>
> > Key words: bone, cartilage, conjugated linoleic acid, rat
>
> > Food Chemistry
> > Volume 100, Issue 3 , 2007, Pages 972-976
>
> > p-Complex formation of conjugated linoleic acid with iron
>
> > Yeonhwa Parka, , , Yeong L. Hab and Michael W. Parizac
>
> > aDepartment of Food Science, University of Massachusetts, 100
> > Holdsworth Way, Amherst, MA 01003, United States
> > bDepartment of Agricultural Chemistry, Gyeongsang National
> > University,
> > Chinju 660-701, Republic of Korea
> > cFood Research Institute, University of Wisconsin-Madison, 1925
> > Willow
> > Drive, Madison, WI 53706, United States
>
> > Received 1 August 2005; revised 3 November 2005; accepted 10
> > November
> > 2005. Available online 20 January 2006.
>
> > Abstract
> > Conjugated linoleic acid (CLA) is known to have several beneficial
> > biological effects in animal models, including anticarcinogenic and
> > antiatherosclerotic effects, antiobesity, and antioxidant activity.
> > However, reports of its antioxidant activities have been
> > inconsistent.
> > In this study, we investigated the possible occurrence of p-bonding
> > between CLA and iron. CLA methyl ester was reacted with triiron
> > dodecacarbonyl and confirmed to form p-complexes with iron
> > tricarbonyl. This study may suggest the possible involvement of CLA
> > in
> > oxidation by way of interacting with iron.
>
> > Keywords: Conjugated linoleic acid; CLA; Iron
>
> > Corresponding author. Tel.: +1 ... =
; fax:
> > +1 413 545 1262.
> > doi:10.1016/j.foodchem.2005.11.006
> > Copyright (c) 2005 Elsevier Ltd All rights reserved
>
> > Who loves ya.
> > Tom
>
> > Jesus Was A Vegetarian! * jesuswasavegetarian.7h . com
>
> > Man Is A Herbivore! * tinyurl . com /a3cc3
>
> > DEAD PEOPLE WALKING * tinyurl . com /zk9fk
>
> > > On Jan 10, 7:26 am, ironjustice <ironjust...@cashette . com >
> > > wrote:"Current treatments use complex proteins, which are expensive to=
> > > makeand cost thousands of dollars per dose. The type of agent used in
> > > this study is a simple, small molecule drug that costs hundreds, not
> > > thousands," Gilbert said. <<
>
> > > Somebody better step in here quick .. this drug also has side
> > > effects .. blinding you to be one.
> > > NOW with the problem with bisphosphonates ?
> > > They are going to be ACTIVELY recruiting for studies of this in ..
> > > those bisphosphonate related diseases ..
>
> > > EVERYONE with .. arthritis ..
>
> > > Whereas .. phytate .. already proven to BE gras / generally regarded
> > > as safe ... ? IE: won't blind you .. ?
>
> > > Who loves ya.
> > > Tom
>
> > > Jesus Was A Vegetarian! * jesuswasavegetarian.7h . com
>
> > > Man Is A Herbivore! * tinyurl . com /a3cc3
>
> > > DEAD PEOPLE WALKING * tinyurl . com /zk9fk
>
> > > > New Treatment Boosts Bone Healing and Re-growth
> > > > Since phytate binds iron and since bisphosphonate binds iron and sin=
ce
> > > > bisphosphonate is used to heal bone .. I would say this study ..
> > > > confirms .. my work ..
>
> > > > IE: phytate WILL grow bone / standin for bisphosphonate.
>
> > > > * w w w .newswise . com /articles/view/536784/
>
> > > > Newswise -- A drug originally used to treat iron poisoning can
> > > > significantly boost the body's own ability to heal and re-grow injur=
ed
> > > > bones, according to researchers at the University of Alabama at
> > > > Birmingham (UAB).
>
> > > > The researchers injected the drug deferoxamine (DF), which is design=
ed
> > > > to reduce iron overload, into injured mouse bones. They found DF
> > > > triggered the growth of new blood vessels, which in turn kicked off
> > > > bone re-growth and healing.
>
> > > > In the study, bone density surrounding the injury more than doubled =
to
> > > > 2.6 cubic millimeters in treated bones compared to 1.2 cubic
> > > > millimeters in untreated bones, the researchers said. The new blood
> > > > vessel growth and bone healing was achieved through a cell pathway
> > > > that helps the body respond to low oxygen levels, a common problem
> > > > when blood supply is affected by bone fracture and disease.
>
> > > > Findings on this cell pathway have broad implications for improving
> > > > treatment of bone fractures, bone disease and other musculoskeletal
> > > > disorders, said Shawn Gilbert, M.D., an assistant professor of
> > > > orthopedic surgery in the UAB School of Medicine, and Chao Wan, M.D.=
> > > > Ph.D., an instructor in the UAB Department of Pathology, both co-
> > > > authors on the study.
>
> > > > "With DF activating this pathway, we've proven a significant point -=
> > > > it is possible to explore new, safe and more affordable ways kick-
> > > > start bone repair," Gilbert said.
>
> > > > "Current treatments use complex proteins, which are expensive to mak=
e
> > > > and cost thousands of dollars per dose. The type of agent used in th=
is
> > > > study is a simple, small molecule drug that costs hundreds, not
> > > > thousands," Gilbert said.
>
> > > > The UAB findings are published in the online version of the journal
> > > > Proceedings of the National Academy of Sciences and will soon appear=
> > > > in a print edition.
>
> > > > "The results from this study are a milestone for future studies
> > > > looking at other compounds and agents to improve new-blood-vessel
> > > > growth in skeletal and other tissues that need adequate blood supply=
> > > > to regenerate," Wan said.
>
> > > > The UAB tests were performed in conjunction with a bone lengthening
> > > > procedure commonly used in children and adults, and has proven to ai=
d
> > > > bone healing. The study mice were anesthetized for surgery, and one
> > > > leg bone was cut clean through and a pulling device attached
> > > > temporarily to stretch the bone gap for the next 10 days.
>
> > > > During the stretching, the bone gap was injected with five DF doses.=
> > > > Two weeks after the last DF dose, X-rays of the mice legs were taken=
> > > > to measure bone regeneration.
>
> > > > DF is a drug that binds to excess iron in the body and helps with
> > > > excretion through the bowels and bladder, a process sometimes called=
> > > > iron chelation. DF is used to treat a variety of medical conditions,=
> > > > including iron overload, transfusion-related blood poisoning and in
> > > > combination with dialysis.
>
> > > > In the findings on post-treatment increased bone density, the UAB
> > > > researchers found significant increases in the number of new blood
> > > > vessels, and excellent connectivity between those vessels. The new
> > > > blood vessels are required regenerate bone of equal or better streng=
th
> > > > than the original bones.
>
> > > > Gilbert said it follows that this cell pathway is a prime target for=
> > > > future human studies using DF and other drugs to strengthen the body=
's
> > > > bone-healing potential, especially since poor blood supply is common=
> > > > in fractures and bone disease.
>
> > > > The research team included UAB investigators from the departments of=
> > > > Surgery, Pathology, and Biomedical Engineering and from Children's
> > > > Hospital of Alabama, Birmingham,
>
> ...
>
> read more »- Hide quoted text -
>
> - Show quoted text -